Isbn: 9783318070101 - fast facts: non-small-cell lung cancer (6 resultados)

ISBN: 
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (6)

a

Intervalo de precios personalizado (EUR)

a

  • Idioma: Inglés

    Editorial: S Karger AG, 2022

    3318070106 / 9783318070101

    • Tapa blanda

    Librería: AwesomeBooks, Wallingford, Reino UnidoAwesomeBooks

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 4,63

    Envío por EUR 5,80 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 1 disponibles

    paperback. Condición: New. Fast Facts: Non-Small-Cell Lung Cancer Brand new item sourced directly from publisher. Packed securely in tight packaging to ensure no damage. Shipped from warehouse on same/next day basis.

  • Idioma: Inglés

    Editorial: S. Karger Karger Mrz 2022, 2022

    3318070106 / 9783318070101

    • Tapa blanda

    Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 19,25

    Envío por EUR 23,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. Neuware -Despite an overall decrease in tobacco use, lung cancer (80-85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer death in both men and women worldwide. Annual low-dose CT screening of high-risk individuals has the potential to detect early-stage tumors, which can usually be successfully treated with a combination of surgery, radiotherapy, and chemotherapy and, in some cases, targeted therapy. However, most patients with NSCLC still present with advanced or metastatic disease. For these patients, initial therapy is guided by the tumor's molecular characteristics and patient's performance status. Targeted therapies have significantly improved clinical outcomes and, for some patients with no targetable genetic alterations, immunotherapy has demonstrated significant overall survival benefit. This insightful guide is designed to bring you up to speed with the latest developments and is important reading for all health professionals and medical trainees working in this fast-moving field. Table of Contents: -Prevention and screening -Diagnosis and staging -Surgery -Radiotherapy -Systemic therapy in non-metastatic NSCLC -Systemic therapy in advanced-stage/metastatic disease without a molecular driver -Personalized treatment in advanced NSCLC -Oligometastatic disease and brain metastases 146 pp. Englisch.…

  • Idioma: Inglés

    Editorial: Karger, S. Karger Mai 2022, 2022

    3318070106 / 9783318070101

    • Tapa blanda

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 19,25

    Envío por EUR 61,20 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. Neuware - Despite an overall decrease in tobacco use, lung cancer (80-85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer death in both men and women worldwide. Annual low-dose CT screening of high-risk individuals has the potential to detect early-stage tumors, which can usually be successfully treated with a combination of surgery, radiotherapy, and chemotherapy and, in some cases, targeted therapy. However, most patients with NSCLC still present with advanced or metastatic disease. For these patients, initial therapy is guided by the tumor's molecular characteristics and patient's performance status. Targeted therapies have significantly improved clinical outcomes and, for some patients with no targetable genetic alterations, immunotherapy has demonstrated significant overall survival benefit. This insightful guide is designed to bring you up to speed with the latest developments and is important reading for all health professionals and medical trainees working in this fast-moving field. Table of Contents: -Prevention and screening -Diagnosis and staging -Surgery -Radiotherapy -Systemic therapy in non-metastatic NSCLC -Systemic therapy in advanced-stage/metastatic disease without a molecular driver -Personalized treatment in advanced NSCLC -Oligometastatic disease and brain metastases.…

  • Idioma: Inglés

    Editorial: Karger, 2022

    3318070106 / 9783318070101

    • Tapa blanda

    Librería: preigu, Osnabrück, Alemaniapreigu

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 19,25

    Envío por EUR 70,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponibles

    Taschenbuch. Condición: Neu. Fast Facts: Non-Small-Cell Lung Cancer | Mary O'Brien (u. a.) | Taschenbuch | Englisch | 2022 | Karger | EAN 9783318070101 | Verantwortliche Person für die EU: Karger Freiburg, Wilhelmstr. 20a, 79098 Freiburg, orders[at]karger[dot]com | Anbieter: preigu.

  • Idioma: Inglés

    Editorial: S. Karger, 2022

    3318070106 / 9783318070101

    • Tapa blanda

    Librería: Buchpark, Trebbin, AlemaniaBuchpark

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Usado - Excelente

    EUR 12,21

    Envío por EUR 105,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponibles

    Condición: Sehr gut. Zustand: Sehr gut | Seiten: 146 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

  • Idioma: Inglés

    Editorial: S. Karger, 2022

    3318070106 / 9783318070101

    • Tapa blanda

    Librería: Buchpark, Trebbin, AlemaniaBuchpark

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Usado

    EUR 12,58

    Envío por EUR 105,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponibles

    Condición: Hervorragend. Zustand: Hervorragend | Seiten: 146 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.